HK1207078A1 - 酶的抑制 - Google Patents
酶的抑制Info
- Publication number
- HK1207078A1 HK1207078A1 HK15107783.9A HK15107783A HK1207078A1 HK 1207078 A1 HK1207078 A1 HK 1207078A1 HK 15107783 A HK15107783 A HK 15107783A HK 1207078 A1 HK1207078 A1 HK 1207078A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- enzymes
- inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12176079 | 2012-07-12 | ||
EP13158756 | 2013-03-12 | ||
PCT/EP2013/064603 WO2014009425A1 (en) | 2012-07-12 | 2013-07-10 | Inhibition of enzymes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1207078A1 true HK1207078A1 (zh) | 2016-01-22 |
Family
ID=48953361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15107783.9A HK1207078A1 (zh) | 2012-07-12 | 2015-08-11 | 酶的抑制 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9199984B2 (zh) |
EP (1) | EP2872509B1 (zh) |
KR (1) | KR20150031318A (zh) |
CN (1) | CN104428300B (zh) |
AR (1) | AR091737A1 (zh) |
BR (1) | BR112015000507A2 (zh) |
CA (1) | CA2878792A1 (zh) |
HK (1) | HK1207078A1 (zh) |
IN (1) | IN2015DN00202A (zh) |
RU (1) | RU2638537C2 (zh) |
WO (1) | WO2014009425A1 (zh) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160097227A (ko) | 2013-12-16 | 2016-08-17 | 키에시 파르마슈티시 엣스. 피. 에이. | 인간 호중구 엘라스타제 억제제로서 테트라하이드로트리아졸로피리미딘 유도체 |
US9487528B2 (en) | 2014-06-09 | 2016-11-08 | Chiesi Farmaceutici S.P.A. | Compounds |
US9657015B2 (en) | 2014-07-31 | 2017-05-23 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9440930B2 (en) | 2014-07-31 | 2016-09-13 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9475779B2 (en) | 2014-07-31 | 2016-10-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
US9409870B2 (en) | 2014-12-15 | 2016-08-09 | Chiesi Farmaceutici S.P.A. | Compounds |
US9802919B1 (en) * | 2016-05-31 | 2017-10-31 | Chiesi Farmaceutici S.P.A. | Compounds |
EP3464268B1 (en) | 2016-05-31 | 2020-03-11 | Chiesi Farmaceutici S.p.A. | Novel compounds |
AR108609A1 (es) | 2016-05-31 | 2018-09-05 | Chiesi Farm Spa | Derivados de imidazolona y pirazolona como inhibidores de la elastasa de neutrófilos humana (hne) |
US11106356B2 (en) | 2017-02-27 | 2021-08-31 | Géza Bálint | Smart device with a display that enables simultaneous multi-functional handling of the displayed information and/or data |
KR20220038403A (ko) | 2019-07-23 | 2022-03-28 | 바이엘 악티엔게젤샤프트 | 살충제로서의 신규 헤테로아릴-트리아졸 화합물 |
JP2022541808A (ja) | 2019-07-23 | 2022-09-27 | バイエル・アクチエンゲゼルシヤフト | 農薬としての新規ヘテロアリール-トリアゾール化合物 |
CN114650819A (zh) | 2019-09-17 | 2022-06-21 | 美莱奥生物制药第四有限公司 | 用于治疗移植物排斥、闭塞性细支气管炎综合征和移植物抗宿主病的阿维来司他 |
CN114728928A (zh) | 2019-10-09 | 2022-07-08 | 拜耳公司 | 作为农药的新的杂芳基三唑化合物 |
WO2021069567A1 (en) | 2019-10-09 | 2021-04-15 | Bayer Aktiengesellschaft | Novel heteroaryl-triazole compounds as pesticides |
KR20220097434A (ko) * | 2019-11-01 | 2022-07-07 | 브리스톨-마이어스 스큅 컴퍼니 | 톨 수용체 억제제로서의 치환된 피라졸 화합물 |
TW202134226A (zh) | 2019-11-18 | 2021-09-16 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基-三唑化合物 |
IL297211A (en) | 2020-04-16 | 2022-12-01 | Mereo Biopharma 4 Ltd | Methods involving the neutrophil elastase inhibitor albalstat for the treatment of respiratory disease mediated by alpha-1 antitrypsin deficiency |
CN113480486B (zh) * | 2021-07-30 | 2022-05-24 | 赣南师范大学 | 一种3-胺基-1,2,4-三唑类衍生物及其制备方法和应用 |
AU2022373971A1 (en) | 2021-10-20 | 2024-04-04 | Mereo Biopharma 4 Limited | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259504A (en) | 1979-08-27 | 1981-03-31 | American Cyanamid Company | Substituted 1H-1,2,4-triazoles |
US4451471A (en) | 1981-03-18 | 1984-05-29 | Ciba-Geigy Corporation | Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same |
US4576958A (en) | 1984-01-23 | 1986-03-18 | E. I. Du Pont De Nemours And Company | Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives |
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
ES2184633B1 (es) | 2001-08-07 | 2004-08-01 | J. URIACH & CIA, S.A. | Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida. |
US6693116B2 (en) * | 2001-10-08 | 2004-02-17 | Hoffmann-La Roche Inc. | Adenosine receptor ligands |
US7524860B2 (en) | 2004-10-07 | 2009-04-28 | Pfizer Inc. | Antibacterial agents |
US7902374B2 (en) | 2005-05-06 | 2011-03-08 | Universal Display Corporation | Stability OLED materials and devices |
US20080125587A1 (en) | 2006-05-25 | 2008-05-29 | Chimmanamada Dinesh U | Synthesis of triazole compounds that modulate HSP90 activity |
CL2008003301A1 (es) * | 2007-11-06 | 2009-10-16 | Astrazeneca Ab | Compuestos derivados de 3,4-dihidropirazina-2-carboxamida, inhibidores de la elastasa de neutrofilos humanos; composiciones farmacéuticas; procesos de preparación de compuestos y composición farmacéutica; y uso en el tratamiento de síndrome de dificultad respiratoria de los adultos, fibrosis quística, cáncer, entre otras. |
PE20091953A1 (es) | 2008-05-08 | 2010-01-09 | Du Pont | Azoles sustituidos como fungicidas |
EP2300466B1 (en) * | 2008-06-20 | 2014-08-06 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors |
US8410128B2 (en) * | 2008-06-20 | 2013-04-02 | Bristol-Myers Squibb Company | Triazolopyridine compounds useful as kinase inhibitors |
DE102009004197A1 (de) * | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Heterocyclisch anellierte Diaryldihydropyrimidin-Derivate und ihre Verwendung |
WO2011039528A1 (en) * | 2009-10-02 | 2011-04-07 | Astrazeneca Ab | 2-pyridone compounds used as inhibitors of neutrophil elastase |
-
2013
- 2013-07-10 IN IN202DEN2015 patent/IN2015DN00202A/en unknown
- 2013-07-10 RU RU2015104644A patent/RU2638537C2/ru not_active IP Right Cessation
- 2013-07-10 CN CN201380036973.4A patent/CN104428300B/zh not_active Expired - Fee Related
- 2013-07-10 KR KR20157002129A patent/KR20150031318A/ko not_active Application Discontinuation
- 2013-07-10 BR BR112015000507A patent/BR112015000507A2/pt not_active IP Right Cessation
- 2013-07-10 WO PCT/EP2013/064603 patent/WO2014009425A1/en active Application Filing
- 2013-07-10 CA CA2878792A patent/CA2878792A1/en not_active Abandoned
- 2013-07-10 EP EP13747801.2A patent/EP2872509B1/en active Active
- 2013-07-11 AR ARP130102470 patent/AR091737A1/es unknown
- 2013-07-12 US US13/940,555 patent/US9199984B2/en not_active Expired - Fee Related
-
2015
- 2015-08-11 HK HK15107783.9A patent/HK1207078A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2872509A1 (en) | 2015-05-20 |
WO2014009425A1 (en) | 2014-01-16 |
US9199984B2 (en) | 2015-12-01 |
BR112015000507A2 (pt) | 2017-06-27 |
CA2878792A1 (en) | 2014-01-16 |
KR20150031318A (ko) | 2015-03-23 |
CN104428300B (zh) | 2016-11-09 |
RU2015104644A (ru) | 2016-08-27 |
IN2015DN00202A (zh) | 2015-06-12 |
EP2872509B1 (en) | 2016-09-14 |
US20140018345A1 (en) | 2014-01-16 |
AR091737A1 (es) | 2015-02-25 |
CN104428300A (zh) | 2015-03-18 |
RU2638537C2 (ru) | 2017-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207078A1 (zh) | 酶的抑制 | |
IL287057A (en) | Purified iduronate-2-sulfatase | |
AP4029A (en) | Inhibitors of beta-secretase | |
ZA201500911B (en) | Enzymes | |
HK1199252A1 (zh) | -活化酶的抑制劑 | |
HK1203949A1 (zh) | 抑制劑 | |
HK1211024A1 (zh) | 的抑制劑 | |
IL236963A0 (en) | beta-secretase inhibitors | |
HK1202053A1 (zh) | 肝臟狀況的治療 | |
HK1201066A1 (zh) | 端錨聚合酶的吡喃並吡啶酮抑制劑 | |
PL2888228T3 (pl) | Inhibitory oddziaływania CD40-TRAF6 | |
GB201207018D0 (en) | Enzymes | |
EP2892529A4 (en) | USES OF (-) - PERHEXILINE | |
GB201215883D0 (en) | Enzyme inhibition | |
GB201215856D0 (en) | Enzyme inhibition | |
GB201114751D0 (en) | Enzyme inhibition | |
GB201114748D0 (en) | Enzyme inhibition | |
GB201223308D0 (en) | Enzyme inhibitors | |
IL233740A0 (en) | Treatment of liver diseases | |
GB201211978D0 (en) | Enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210707 |